EUVIMEDEUVIMED entdecken
Multizentrische Studie

Late Preterm Antenatal Corticosteroids in Pregestational and Gestational Diabetic Pregnancies

Lylach Haizler-Cohen iD, Maria C Alzamora, Nicole R Legro, Leila Eter, Tasha Freed, Suditi Rahematpura, Ayah Arafat, Victoria Greenberg, Sara N Iqbal

American Journal of Perinatology · 01.10.2025 · 42 (14) · 1798-1808

DOI: 10.1055/a-2624-8405 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.10.2025. Verfasst von Lylach Haizler-Cohen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, MedStar Washington Hospital Center, Washington, District of Columbia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Hypoglycemia, Pregnancy in Diabetics, Adrenal Cortex Hormones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Medstar Health Graduate Medical Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to evaluate the association between late preterm antenatal corticosteroids (ACS) administration and the incidence of hypoglycemia and respiratory complications in neonates born to individuals with pregestational diabetes mellitus (PGDM) and gestational diabetes mellitus (GDM). Multi-center retrospective cohort study between 2016 and 2022. Pregnant people with PGDM or GDM who presented in the late preterm period with concern for preterm delivery were included. The indication for admission was classified as preterm labor, preterm prelabor rupture of membranes, poorly controlled diabetes, or other maternal/fetal indications. Exclusion criteria included multifetal gestations, fetal anomalies, stillbirths, prior course of ACS, or no anticipation for delivery in the next 7 days. The primary outcome was neonatal hypoglycemia. Secondary outcomes included composite respiratory morbidity, composite nonrespiratory morbidity, neonatal intensive care unit (NICU) admission, length of NICU stay, and neonatal death. Multivariable regression models were used to calculate the odds ratio and 95% confidence intervals for the outcomes after adjusting for an indication for admission, gestational age at delivery, and neonatal birth weight. Outcome data were then stratified by diabetes type (PGDM vs. GDM) and completion status of the ACS course (partial vs. complete). For PGDM pregnancies, outcome data were additionally stratified by glycemic control. In the study period, 453 patients (126 with PGDM and 327 with GDM) were included. Of those, 265 (58.5%) received ACS, and 188 (41.5%) did not. There were no significant differences in neonatal hypoglycemia and composite respiratory morbidity between the ACS and non-ACS groups, including in the subgroup analysis of PGDM and GDM pregnancies. However, late preterm ACS was associated with reductions in supplemental oxygen use, mechanical ventilation, and respiratory distress syndrome when a complete course of ACS was administered. In PGDM pregnancies, neonatal outcomes did not differ between the ACS and non-ACS groups, regardless of glycemic control. Late preterm ACS administration in diabetic pregnancies was not associated with increased neonatal hypoglycemia or improvements in composite respiratory morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalHypoglycemiaPregnancy in DiabeticsAdrenal Cortex HormonesHumansFemalePregnancyRetrospective StudiesInfant, NewbornAdultRespiratory Distress Syndrome, NewbornGestational AgePremature BirthIntensive Care Units, NeonatalPrenatal Care

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, MedStar Washington Hospital Center, Washington, District of Columbia.
  • Georgetown University School of Medicine, Washington, District of Columbia.
  • MedStar Health Research Institute, Hyattsville, Maryland.

ORCID-Profile: Lylach Haizler-Cohen

Förderung

  • Medstar Health Graduate Medical Education

Zitieren

APA

Haizler-Cohen, L., Alzamora, M. C., Legro, N. R., Eter, L., Freed, T., Rahematpura, S., Arafat, A., Greenberg, V., & Iqbal, S. N. (2025). Late Preterm Antenatal Corticosteroids in Pregestational and Gestational Diabetic Pregnancies. American Journal of Perinatology, 42(14), 1798-1808. https://doi.org/10.1055/a-2624-8405

Vancouver

Haizler-Cohen L, Alzamora MC, Legro NR, Eter L, Freed T, Rahematpura S, et al. Late Preterm Antenatal Corticosteroids in Pregestational and Gestational Diabetic Pregnancies. American Journal of Perinatology. 2025;42(14):1798-1808. doi:10.1055/a-2624-8405

BibTeX
@article{HaizlerCohen2025,
  author = {Haizler-Cohen, Lylach and Alzamora, Maria C and Legro, Nicole R and Eter, Leila and Freed, Tasha and Rahematpura, Suditi and Arafat, Ayah and Greenberg, Victoria and Iqbal, Sara N},
  title = {Late Preterm Antenatal Corticosteroids in Pregestational and Gestational Diabetic Pregnancies},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {14},
  pages = {1798--1808},
  doi = {10.1055/a-2624-8405}
}
Kostenlos starten →